Intellia Therapeutics Inc (38I.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
As of 04:30PM CEST. Market open.
| Previous close | 22.02 |
| Open | 21.78 |
| Bid | 22.19 x N/A |
| Ask | 22.37 x N/A |
| Day's range | 21.78 - 21.86 |
| 52-week range | 18.43 - 42.95 |
| Volume | |
| Avg. volume | 7 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
In the latest trading session, Intellia Therapeutics, Inc. (NTLA) closed at $23.60, marking a +1.42% move from the previous day.
- Zacks
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
On Intellia's (NTLA) first-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline of genome-editing candidates.
© 2024 Yahoo. All rights reserved.